CO5200850A1 - Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion - Google Patents
Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacionInfo
- Publication number
- CO5200850A1 CO5200850A1 CO00057176A CO00057176A CO5200850A1 CO 5200850 A1 CO5200850 A1 CO 5200850A1 CO 00057176 A CO00057176 A CO 00057176A CO 00057176 A CO00057176 A CO 00057176A CO 5200850 A1 CO5200850 A1 CO 5200850A1
- Authority
- CO
- Colombia
- Prior art keywords
- influenza
- treatment
- profilaxis
- flu
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición que incluye una fitoalexina estilbénica usada en un método para la profilaxis y tratamiento de síntomas del resfriado y similares a la influenza que comprende la administración de dicha composición a un sujeto, la cual tiene la estructura: <EMI FILE="00057176_1" ID="1" IMF=JPEG > en donde R1, R2, R3, R4, R5 y R6 independientemente se seleccionan de hidrógeno e hidroxi; y sales o ésteres medicinalmente aceptables de éstos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36494499A | 1999-07-30 | 1999-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5200850A1 true CO5200850A1 (es) | 2002-09-27 |
Family
ID=23436803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00057176A CO5200850A1 (es) | 1999-07-30 | 2000-07-31 | Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1221949A2 (es) |
JP (1) | JP2003505500A (es) |
CN (1) | CN1377262A (es) |
AU (1) | AU6240200A (es) |
CA (1) | CA2379703A1 (es) |
CO (1) | CO5200850A1 (es) |
HK (1) | HK1049104A1 (es) |
PE (1) | PE20010540A1 (es) |
TR (1) | TR200200246T2 (es) |
WO (1) | WO2001008671A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
ITRM20020562A1 (it) * | 2002-11-06 | 2004-05-07 | Sigma Tau Ind Farmaceuti | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
AU2006210119B2 (en) | 2005-02-04 | 2011-09-22 | Peter Heger | Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints |
DE602006013787D1 (de) * | 2006-03-28 | 2010-06-02 | Epitech Group Srl | Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden |
CN100453071C (zh) * | 2006-11-03 | 2009-01-21 | 李万忠 | 白藜芦醇口服多相脂质体及其制备方法 |
JPWO2008136173A1 (ja) * | 2007-04-20 | 2010-07-29 | 国立大学法人お茶の水女子大学 | スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤 |
US20090175803A1 (en) | 2008-01-08 | 2009-07-09 | David Rubin | Method and compositions for administering resveratrol and pterostilbene |
FR2933871B1 (fr) * | 2008-07-18 | 2012-12-14 | Yvery | Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe |
ES2592528T3 (es) * | 2010-03-12 | 2016-11-30 | Synairgen Research Limited | Interferón beta para uso en el tratamiento de enfermedades de las vías respiratorias inferiores causada por influenza |
JP5848042B2 (ja) | 2011-06-29 | 2016-01-27 | 株式会社ロッテ | 眼疲労抑制組成物及びそれを含む飲食品 |
KR20140108633A (ko) * | 2011-10-19 | 2014-09-12 | 나드 라이프 피티와이 엘티디 | 레스베라트롤의 약학 조성물 |
CN106581028A (zh) * | 2016-11-30 | 2017-04-26 | 南宁市浩特竹鼠养殖场 | 一种治疗竹鼠感冒的西药及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0753359A (ja) * | 1993-06-11 | 1995-02-28 | Kao Corp | リポキシゲナーゼ阻害剤 |
FR2778337B1 (fr) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
US6197834B1 (en) * | 1998-09-01 | 2001-03-06 | Northeastern Ohio Universities College Of Medicine | Method of inhibiting formation of infectious herpes virus particles |
CA2339049C (en) * | 1998-09-08 | 2010-02-23 | Cornell Research Foundation, Inc. | Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
-
2000
- 2000-07-26 PE PE2000000750A patent/PE20010540A1/es not_active Application Discontinuation
- 2000-07-28 AU AU62402/00A patent/AU6240200A/en not_active Abandoned
- 2000-07-28 TR TR2002/00246T patent/TR200200246T2/xx unknown
- 2000-07-28 CA CA002379703A patent/CA2379703A1/en not_active Abandoned
- 2000-07-28 JP JP2001513401A patent/JP2003505500A/ja not_active Withdrawn
- 2000-07-28 EP EP00948987A patent/EP1221949A2/en not_active Withdrawn
- 2000-07-28 CN CN00810896A patent/CN1377262A/zh active Pending
- 2000-07-28 WO PCT/US2000/020658 patent/WO2001008671A2/en not_active Application Discontinuation
- 2000-07-31 CO CO00057176A patent/CO5200850A1/es not_active Application Discontinuation
-
2002
- 2002-12-19 HK HK02109229.2A patent/HK1049104A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001008671A3 (en) | 2002-05-02 |
WO2001008671A2 (en) | 2001-02-08 |
HK1049104A1 (zh) | 2003-05-02 |
CA2379703A1 (en) | 2001-02-08 |
TR200200246T2 (tr) | 2002-09-23 |
JP2003505500A (ja) | 2003-02-12 |
PE20010540A1 (es) | 2001-05-15 |
EP1221949A2 (en) | 2002-07-17 |
CN1377262A (zh) | 2002-10-30 |
AU6240200A (en) | 2001-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2524458T3 (es) | DNasa para el tratamiento de la subfertilidad masculina | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
DE60143393D1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
CO5160320A1 (es) | Metodos y composiciones para la prevencion de tolerancia a medicamentos das. | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
JP2005532372A5 (es) | ||
UY28041A1 (es) | Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial. | |
ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
CO5200850A1 (es) | Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion | |
BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
BR9509019A (pt) | Processo para fabricar unidades de dosagem farmacêutica e comprimido isento de solventes orgânicos | |
DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
DE60322075D1 (de) | Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen | |
ES2170143T3 (es) | Composiciones que comprenden halofantrina en una forma especial. | |
DK1082131T3 (da) | Immunoregulator | |
AR032614A1 (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
CO5690571A2 (es) | Combinacion sinergica que comprende roflumilas y (r,r)-formoterol | |
AR018376A1 (es) | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento | |
NO20031650D0 (no) | Nye legemidler for leversykdommer | |
HUP0301831A2 (hu) | Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére | |
BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
DK1227826T3 (da) | Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf | |
ATE261732T1 (de) | Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |